Katsushi Tanaka

<scp>MicroRNA</scp>‐200b is a potential biomarker of the expression of <scp>PD‐L1</scp> in patients with lung cancer

Seigo Katakura, Nobuaki Kobayashi, Hisashi Hashimoto et al. · Thoracic Cancer · 2020 · 20 citations · Full text

Medicine, Immunology, Oncology +16

Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non‐small‐cell lung cancer: A multicenter retrospective trial

Hiromi Matsumoto, Nobuaki Kobayashi, Kohei Somekawa et al. · Thoracic Cancer · 2021 · 16 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in Japan

Seigo Katakura, Nobuaki Kobayashi, Hisashi Hashimoto et al. · Tuberculosis · 2020 · 15 citations

Public Health, Immunology, Infectious Diseases +17

Effectiveness of BA.1- and BA.4/BA.5-containing bivalent COVID-19 mRNA vaccines against symptomatic SARS-CoV-2 infection during the BA.5-dominant period in Japan

Takeshi Arashiro, Yuzo Arima, Jin Kuramochi et al. · Open Forum Infectious Diseases · 2023 · 15 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: a multicenter prospective study

Hiroaki Fujii, Hideyuki Nagakura, Nobuaki Kobayashi et al. · BMC Cancer · 2022 · 12 citations · Full text

Medicine, Oncology, Pathology +17